These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1028 related items for PubMed ID: 16703718

  • 1. Recurrent vulvovaginal candidiasis.
    Ringdahl EN.
    Mo Med; 2006; 103(2):165-8. PubMed ID: 16703718
    [Abstract] [Full Text] [Related]

  • 2. Treatment of recurrent vulvovaginal candidiasis.
    Ringdahl EN.
    Am Fam Physician; 2000 Jun 01; 61(11):3306-12, 3317. PubMed ID: 10865926
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.
    Diabetes Care; 2007 Feb 01; 30(2):312-7. PubMed ID: 17259500
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
    Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L.
    Akush Ginekol (Sofiia); 2005 Feb 01; 44 Suppl 2():25-7. PubMed ID: 16028400
    [Abstract] [Full Text] [Related]

  • 5. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
    Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC.
    N Engl J Med; 2004 Aug 26; 351(9):876-83. PubMed ID: 15329425
    [Abstract] [Full Text] [Related]

  • 6. [Vulvovaginal candidiasis: a therapeutic approach].
    Battaglia F, Mariani L, Anglana F, Milite V, Quattrini M, Plotti F, Tomao F, Plotti G.
    Minerva Ginecol; 2005 Apr 26; 57(2):131-9. PubMed ID: 15940073
    [Abstract] [Full Text] [Related]

  • 7. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M, Schaller M, Weissenbacher ER.
    Mycoses; 2015 Mar 26; 58 Suppl 1():1-15. PubMed ID: 25711406
    [Abstract] [Full Text] [Related]

  • 8. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.
    Ventolini G, Baggish MS, Walsh PM.
    J Reprod Med; 2006 Jun 26; 51(6):475-8. PubMed ID: 16846086
    [Abstract] [Full Text] [Related]

  • 9. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
    Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME.
    J Womens Health (Larchmt); 2011 Aug 26; 20(8):1245-55. PubMed ID: 21774671
    [Abstract] [Full Text] [Related]

  • 10. Boric acid treatment of vulvovaginal candidiasis.
    Swate TE, Weed JC.
    Obstet Gynecol; 1974 Jun 26; 43(6):893-5. PubMed ID: 4597792
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genotyping and drug resistance profile of Candida spp. in recurrent and one-off vaginitis, and high association of non-albicans species with non-pregnant status.
    Chong PP, Abdul Hadi SR, Lee YL, Phan CL, Tan BC, Ng KP, Seow HF.
    Infect Genet Evol; 2007 Jul 26; 7(4):449-56. PubMed ID: 17324639
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recurrent vulvovaginitis candidiasis; an overview of traditional and alternative therapies.
    Wilson C.
    Adv Nurse Pract; 2005 May 26; 13(5):24-9; quiz 30. PubMed ID: 15898312
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Azole resistant Candida glabrata vulvovaginitis treated with boric acid.
    Savini V, Catavitello C, Bianco A, Balbinot A, D'Antonio F, D'Antonio D.
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov 26; 147(1):112. PubMed ID: 19619928
    [No Abstract] [Full Text] [Related]

  • 18. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis.
    Ray D, Goswami R, Dadhwal V, Goswami D, Banerjee U, Kochupillai N.
    J Infect; 2007 Oct 26; 55(4):374-7. PubMed ID: 17692922
    [Abstract] [Full Text] [Related]

  • 19. Management of patients with recurrent vulvovaginal candidiasis.
    Sobel JD.
    Drugs; 2003 Oct 26; 63(11):1059-66. PubMed ID: 12749733
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.